Literature DB >> 438232

Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(DL-lactic acid), and their copolymers.

C G Pitt, A R Jeffcoat, R A Zweidinger, A Schindler.   

Abstract

The maximum steady state flux, diffusion coefficients, and solubilities of five contraceptive steroids in homopolymers and copolymers of epsilon-caprolactone and DL-lactic acid were determined. The permeabilities of polymers of epsilon-caprolactone were comparable to silicone rubber and, by inference, are suitable for the construction of drug delivery devices. Poly(DL-lactic acid) was 10(4) times less permeable, although its permeability was significantly enhanced by additives.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438232     DOI: 10.1002/jbm.820130313

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  13 in total

1.  Controlled-release systemic delivery - a new concept in cancer chemoprevention.

Authors:  Ramesh C Gupta; Shyam S Bansal; Farrukh Aqil; Jeyaprakash Jeyabalan; Pengxiao Cao; Hina Kausar; Gilandra K Russell; Radha Munagala; Srivani Ravoori; Manicka V Vadhanam
Journal:  Carcinogenesis       Date:  2012-06-13       Impact factor: 4.944

Review 2.  Long-acting injectable hormonal dosage forms for contraception.

Authors:  Linfeng Wu; Dileep R Janagam; Timothy D Mandrell; James R Johnson; Tao L Lowe
Journal:  Pharm Res       Date:  2015-04-22       Impact factor: 4.200

3.  Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies.

Authors:  Dinesh Shenoy; Steven Little; Robert Langer; Mansoor Amiji
Journal:  Pharm Res       Date:  2005-11-03       Impact factor: 4.200

4.  Intravascular tissue reactions induced by various types of bioabsorbable polymeric materials: correlation between the degradation profiles and corresponding tissue reactions.

Authors:  Ichiro Yuki; Naoyuki Uchiyama; Yuichi Murayama; Yih-Lin Nien; Daniel Lee; Masaki Ebara; Akira Ishii; Alexander Chiang; Harry V Vinters; Ichiro Nishimura; Benjamin M Wu; Fernando Vinuela
Journal:  Neuroradiology       Date:  2010-02-10       Impact factor: 2.804

5.  Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin.

Authors:  Shyam S Bansal; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Pharm Res       Date:  2011-02-11       Impact factor: 4.200

6.  In vitro evaluation of sustained drug release from biodegradable elastomer.

Authors:  R Wada; S H Hyon; T Nakamura; Y Ikada
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

7.  Chemical functionalization of bone implants with nanoparticle-stabilized chitosan and methotrexate for inhibiting both osteoclastoma formation and bacterial infection.

Authors:  Li-Hua Li; Mei Li; Dan Li; Peng He; Hong Xia; Yu Zhang; Chuanbin Mao
Journal:  J Mater Chem B       Date:  2014-09-28       Impact factor: 6.331

8.  Hydrolytic degradation of PCL/PEO copolymers in alkaline media.

Authors:  S M Li; X H Chen; R A Gross; S P McCarthy
Journal:  J Mater Sci Mater Med       Date:  2000-04       Impact factor: 3.896

9.  Accelerated degradation of poly(epsilon-caprolactone) by organic amines.

Authors:  W J Lin; D R Flanagan; R J Linhardt
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

10.  An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.

Authors:  Niina Ahola; Noora Männistö; Minna Veiranto; Matti Karp; Jaana Rich; Alexander Efimov; Jukka Seppälä; Minna Kellomäki
Journal:  Biomatter       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.